Dr. Deiuliis’s initial training was in the field of dietary chemoprevention, although he received a doctorate in the regulation of adipocyte lipolysis. Dr. Deiuliis’s post-doctoral training was in the Heart and Lung Research Institute at the Ohio State University, where he trained and worked as a research scientist in the laboratory of Dr. Sanjay Rajagopalan. His research focus was directed on human obesity and the pathophysiological changes associated with insulin resistance. While there, he received an Individual Postdoctoral Fellow Award (NIH F32 NRSA).
Dr. Deiuliis joined the faculty of University of Maryland, Baltimore in late 2013 and began work on his K01 grant from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) in 2014.
Dr. Deiuliis’s research focuses on multiple aspects of the development of insulin resistance and metabolic dysfunction in obesity. He is part of a team with a particular interest in immune-mediated visceral adipose inflammation in the etiology of obesity-related cardiometabolic disease such as insulin resistance. Recent research has centered on the role of microRNAs (miRNA) in the process of macrophage activation in obesity. The team examines visceral adipose from obese humans undergoing weight loss surgery compared to lean control patients and utilizes bioinformatics platforms to predict miRNA binding and model potential cellular interactions on metabolic and inflammatory pathways. Human findings are further examined using murine models of insulin resistance and in vitro methods to assess miRNA effects on pathways of interest.
Faculty members: Update your contact information and create a profile.